FDA developing new rules for artificial intelligence in medicine
on Tue, 2019-04-02 00:00 Alyssa
The Food and Drug Administration announced Tuesday that it is developing a framework for regulating artificial intelligence products used in medicine that continually adapt based on new data.
The agency’s outgoing commissioner, Scott Gottlieb, released a white paper that sets forth the broad outlines of the FDA’s proposed approach to establishing greater oversight over this rapidly evolving segment of AI products.
Links:
[1] https://www.statnews.com/2019/04/02/fda-new-rules-for-artificial-intelligence-in-medicine/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=71406341&_hsenc=p2ANqtz-9MVmdB8HcKbjr1rDLdzdohfNhW92jDMqMDuN4x0MTF_eogpI_O9x3f7WLHrn9JiSEEpW8-n8yoftd-AqjYyRas0aCovw&_hsmi=71406341